Catalys represents BioVectra in France
BioVectra Inc. is an Eastern Canadian supplier to the global pharmaceutical and biotechnology industries, operating from three, FDA-inspected facilities. This agile and steadily growing company has been in business since 1970, and has an impressive track-record in the quality of services and products provided to its global customer base.
It is also ideally located to produce for the North American markets.
Facilities are equipped to provide synthetic organic chemistry, natural extraction of bioactive compounds from both plant and animal-based biomass sources, PEGylation and conjugation chemistry, and fermentation of a variety of molecule types.
A key component of BioVectra’s service is their Quality history :
To date, BioVectra has filed 7 DMF’s, 3 VMF’s, 1 ANDA and CMC section preparations for both the United States Food and Drug Administration (U.S. FDA), and Health Canada. These filings have been made for both synthetic and biologic molecules, and include a human injectable API, as well as a final drug product.
BioVectra is ‘bridging chemistry and biotechnology‘ – offering drug development companies a unique mix of skills that can be applied to molecules requiring more than one processing technique, and an ability to be a full-service, drug development partner.
To learn more about BioVectra please visit the following links :
Do not hesitate to contact us about Biovectra products and services.